Kanazawa H, Hirata K, Yoshikawa J
Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abenoku, Japan.
Thorax. 2002 Oct;57(10):885-8. doi: 10.1136/thorax.57.10.885.
There is evidence that the bronchial microcirculation has the potential to contribute to the pathophysiological mechanisms of exercise induced bronchoconstriction (EIB) in asthmatic subjects. Vascular endothelial growth factor (VEGF), which is highly expressed in asthmatic airways, increases vascular permeability. The relationship between VEGF levels in induced sputum and the severity of EIB in asthmatic subjects was studied.
The concentration of VEGF in induced sputum was examined in 23 asthmatic subjects and 11 normal controls. The asthmatic subjects performed an exercise test and the % maximal fall in forced expiratory volume in 1 second (FEV(1)) was measured. Beclomethasone dipropionate (BDP) 400 micro g twice daily was administered to the asthmatic subjects for 8 weeks and the exercise test and sputum induction were repeated.
The concentration of VEGF in induced sputum was significantly higher in asthmatic subjects than in normal controls. There was a significant correlation between the concentration of VEGF and the % maximal fall in FEV(1) (r=0.826, p=0.0001) and between the concentration of VEGF and airway vascular permeability index (r=0.621, p=0.0037). After treatment with inhaled BDP there was a significant decrease in the concentration of VEGF in the asthmatic subjects (before treatment: 7051 (2361) pg/ml, after treatment: 4498 (2135) pg/ml, p<0.0001). The change in the concentration of VEGF was significantly correlated with the change in the % maximal fall in FEV(1) (r=0.463, p=0.031).
Excessive production of VEGF in asthmatic airways may contribute to the pathogenesis of EIB via increased airway vascular permeability.
有证据表明,支气管微循环可能参与哮喘患者运动诱发支气管收缩(EIB)的病理生理机制。血管内皮生长因子(VEGF)在哮喘气道中高表达,可增加血管通透性。本研究旨在探讨哮喘患者诱导痰中VEGF水平与EIB严重程度之间的关系。
检测23例哮喘患者和11例正常对照者诱导痰中VEGF的浓度。哮喘患者进行运动试验,测量第1秒用力呼气容积(FEV₁)的最大下降百分比。对哮喘患者给予丙酸倍氯米松(BDP)400μg,每日2次,治疗8周,然后重复运动试验和痰液诱导。
哮喘患者诱导痰中VEGF浓度显著高于正常对照者。VEGF浓度与FEV₁最大下降百分比之间存在显著相关性(r = 0.826,p = 0.0001),VEGF浓度与气道血管通透性指数之间也存在显著相关性(r = 0.621,p = 0.0037)。吸入BDP治疗后,哮喘患者VEGF浓度显著降低(治疗前:7051(2361)pg/ml,治疗后:4498(2135)pg/ml,p < 0.0001)。VEGF浓度的变化与FEV₁最大下降百分比的变化显著相关(r = 0.463,p = 0.031)。
哮喘气道中VEGF的过度产生可能通过增加气道血管通透性促进EIB的发病机制。